| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $14.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $75.91 | $1,897,747.33 | -1.4% | -33.5% | -29.8% | |
| Jun 29, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $61.59 | $1,539,861.52 | -4.1% | +1.0% | -9.5% | |
| Aug 5, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 30,000 | $128.78 | $3,863,468.55 | -2.5% | -27.4% | -39.0% | |
| Jun 15, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 30,000 | $126.43 | $3,792,804.19 | -4.9% | -4.5% | -49.3% | |
| Jan 15, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $213.67 | $4,273,311.04 | -1.7% | - | - | |
| Dec 10, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $142.29 | $2,845,781.82 | -2.2% | - | - | |
| Jun 1, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 17,275 | $64.68 | $1,117,265.50 | -3.1% | - | - | |
| May 20, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 15,000 | $65.25 | $978,683.16 | -4.2% | - | - | |
| Jun 17, 2019 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $46.00 | $920,000.00 | -10.8% | - | - | |
| Apr 29, 2019 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $42.03 | $840,600.00 | -10.7% | - | - |